6550--580-25-2-026-0032 Reagents for BioFire Analyzer (VA-25-00011404)
ID: 36C25625Q0166Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF256-NETWORK CONTRACT OFFICE 16 (36C256)RIDGELAND, MS, 39157, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Veterans Affairs is seeking vendors to provide reagents for the BioFire Analyzer at the Michael E. DeBakey VA Medical Center in Houston, Texas. This Sources Sought Notice aims to identify potential sources to inform the procurement strategy for a forthcoming solicitation, which includes specific reagents and quantities necessary for diagnostic purposes. The anticipated contract will be a Single Award, Firm Fixed Price with a one-year ordering period, and responses are encouraged from both small and large businesses, particularly those compliant with the Non-Manufacturer Rule and authorized distributors of OEM parts. Interested parties must submit their responses, including market pricing estimates, by November 29, 2024, to Contracting Officer Shasta Britt at shasta.britt@va.gov.

    Point(s) of Contact
    Shasta BrittContracting Officer
    (713) 791-1414
    Shasta.Britt@va.gov
    Files
    Title
    Posted
    The Department of Veterans Affairs is seeking information through a Sources Sought Notice to identify vendors for reagents needed for the BioFire Analyzer at the Michael E. DeBakey VA Medical Center in Houston, Texas. This RFI is not a solicitation but aims to inform the procurement strategy for future contracts regarding supply needs. The request includes a list of specific reagents, quantities, and potential contract terms, including a one-year ordering period with a Single Award, Firm Fixed Price approach. Vendors are encouraged to respond with information about their capabilities, including the manufacturing source, size classification (small or large business), compliance with the Non-Manufacturer Rule, and distribution authorization with OEM parts. Responses must also include market pricing estimates to gauge competition and pricing landscape in the industry. All information provided is for market research purposes and will remain confidential within the MEDVAMC purchasing team. Responses are due by November 29, 2024, and must adhere to specified formatting guidelines.
    Lifecycle
    Similar Opportunities
    Sources Sought Phadia Test Kits and Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 5, is seeking sources for the procurement of Phadia test kits and supplies, including reagents for its ImmunoCap Allergy and ELiA Autoimmunity solutions. This Sources Sought Notice is intended for planning purposes only and will not result in a contract award; it aims to gather information on available suppliers and their capabilities. The anticipated procurement will be structured as a firm-fixed-price Indefinite Delivery Indefinite Quantity contract, potentially spanning five years, with deliveries to the VAMHCS Baltimore warehouse. Interested suppliers must respond by January 6, 2025, providing company details and socio-economic status to Alison Klein at ALISON.KLEIN@VA.GOV.
    Sources Sought Notice - Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to include reagents, molecular PCR instrument/equipment, consumables, maintenance support and instrument warranties at BAMC.
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to support molecular genetic and infectious disease testing at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of molecular PCR instruments, reagents, consumables, maintenance support, and instrument warranties, with a base performance period from October 1, 2025, to September 30, 2030. This initiative is critical for enhancing the laboratory's capabilities in conducting various genetic tests, including those for Celiac Disease, Alzheimer’s Disease, and a comprehensive Dermatomycosis Panel, which are essential for informed health assessments and treatment decisions. Interested parties are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil, by the specified deadlines, as this notice is solely for information and planning purposes and does not constitute a solicitation.
    6640--06 BACT/ALERT VIRTUO Blood Culture System, Consumables, and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to establish a sole-source Indefinite Delivery Indefinite Quantity (IDIQ) contract for the BACT/ALERT VIRTUO Blood Culture System, including necessary consumables and support services, to be utilized across multiple laboratories within VISN 6. This procurement aims to ensure the provision of a fully automated blood culture testing system, which is critical for healthcare services provided to veterans, with the contract expected to commence on November 29, 2024. The decision to pursue a sole-source contract with BioMerieux Incorporated follows market research indicating that these specialized items are exclusively available from the original equipment manufacturer, thereby avoiding delays and additional costs. Interested parties may express their capabilities to Contract Specialist Stephanie McElmore via email by November 19, 2024, and should clearly indicate their business status regarding size and ownership.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    6640--VISN Blanket Purchase Agreement NEW Coagulation CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a Blanket Purchase Agreement (BPA) to acquire coagulation analyzers, related equipment, reagents, and services for various VA medical facilities. The procurement aims to ensure the availability of high-quality coagulation testing capabilities, which are critical for patient diagnosis and treatment, over a five-year term from February 1, 2025, to January 31, 2030. This opportunity emphasizes compliance with federal guidelines, including cybersecurity measures for medical devices, and prioritizes service-disabled veteran-owned businesses. Interested vendors must submit their proposals by January 6, 2025, and can contact Contracting Specialist Lindsey M Zwaagstra at Lindsey.Zwaagstra@va.gov for further information.
    6550--Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to negotiate a sole source contract with Microgenics Corporation for the procurement of FDA-approved Microgenics DRI Ecstasy Plus Assay Reagent, which is essential for use with Beckman AU480 Analyzers at the Minneapolis VA Medical Center. This contract action is being pursued under the authority of FAR 13.106-1, which allows for sole source awards when only one source is available to meet the government's requirements. The reagents are critical for in-vitro diagnostic testing, ensuring accurate and timely results for patient care. Interested vendors who believe they can meet the requirements are invited to submit a capability statement by 12:00 PM Central Time on January 9, 2025, to Alisha Milander at Alisha.Milander@va.gov, with all submissions needing to include registration details in the System for Award Management (SAM).
    6640--NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract to Illumina, Inc. for the provision of molecular testing reagents required by the Minneapolis VA Health Care System. This procurement involves a Firm Fixed Price Purchase Order for a base year plus four option years, specifically for next-generation sequencing reagents that are compatible with the VA's existing Illumina sequencers. The sole-source justification is based on the fact that Illumina is the only authorized supplier for these specialized reagents, with no alternative products approved for use on the VA's equipment. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by January 10, 2025, to the Contracting Officer, Traci Johannes, at traci.johannes@va.gov.
    Q301--VISN22 REFERENCE LAB TESTING SERVICES
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide Reference Lab Testing Services under the solicitation number 36C26225Q0310 for various facilities within the Veterans Integrated Service Network 22 (VISN 22), which includes locations in California, New Mexico, Arizona, and associated outpatient clinics. The objective is to establish a single Indefinite Delivery/Indefinite Quantity (IDIQ) contract that encompasses specimen processing, testing with defined turnaround times, secure courier transportation, and compliance with cybersecurity and HIPAA protocols. This initiative is crucial for ensuring timely and efficient laboratory services for veterans' healthcare, with a contract budget ranging from $1,000 to $50 million, and implementation expected within 120 days of award. Interested parties must submit their capability statements by February 4, 2025, and can contact Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov for further information.
    6630--Sources Sought - BPA for NCO20 Urinalysis Testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20 (NCO20), is seeking qualified vendors to establish a Blanket Purchase Agreement (BPA) for urinalysis testing services across various medical facilities within the Veterans Integrated Service Network (VISN) 20. The procurement aims to secure automated clinical laboratory urinalysis testing, including the provision of necessary equipment, reagents, and maintenance services, with a contract term consisting of a base year plus four option years. This initiative is crucial for ensuring efficient and reliable laboratory services to support the healthcare needs of veterans, with an estimated annual testing volume of approximately 91,740 urine microscopies and 126,410 urine chemistries across multiple locations. Interested vendors, particularly Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Businesses (VOSB), must submit their capabilities statements and pricing information to Contract Specialist Peter Park at peter.park2@va.gov by January 7, 2025, to be considered for this opportunity.